InMed Pharmaceuticals Balance Sheet (2019-2026)

Reported Financials

InMed Pharmaceuticals Quarterly Balance Sheet

Periods 27 quarters

Latest Mar 2026

InMed Pharmaceuticals reported total assets of $9.13M and total liabilities of $2.24M for the quarter ended Mar 2026, down 1.6% year over year. This balance sheet covers 27 quarters of results from Sep 2019 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	7.36M	15.39M	11.33M	5.94M	6.18M	9.35M	11.50M	9.65M	8.91M	6.74M	9.53M	7.60M	6.57M	5.60M	3.50M	4.70M	10.74M	9.40M	7.00M	5.20M
Short-term InvestmentsInvestments (Current)	0.05M	0.05M	0.05M	0.05M	0.04M	0.04M	0.04M	0.04M	0.04M	0.04M	0.04M	0.04M	0.04M	0.04M	0.04M	0.04M	0.04M	0.04M	0.04M	0.04M
Cash & Current Investments	7.41M	15.43M	11.37M	5.99M	6.22M	9.39M	11.54M	9.69M	8.96M	6.78M	9.58M	7.64M	6.61M	5.64M	3.54M	4.74M	10.79M	9.44M	7.04M	5.24M
Receivables - NetNet Receivables	0.01M	0.01M	0.05M	0.07M	0.02M	0.02M	0.08M	0.17M	0.07M	0.17M	0.37M	0.21M	0.03M	0.28M	0.26M	0.37M	0.47M	0.34M	0.18M
Receivables	0.01M	0.01M	0.05M	0.07M	0.02M	0.02M	0.08M	0.17M	0.07M	0.17M	0.37M	0.21M	0.03M	0.28M	0.26M	0.37M	0.47M	0.34M	0.18M
Raw Materials					0.29M		0.21M	0.39M	0.21M	0.21M		0.20M	0.37M	0.27M	0.17M	0.26M	0.26M	0.17M
Work In Process					1.72M		0.80M	0.55M	0.51M	0.09M	0.19M	0.44M	0.03M	0.02M	0.26M	0.32M	0.03M	0.42M	0.57M
Finished Goods					0.47M		0.61M	0.39M	0.89M	0.84M	0.56M	0.56M	0.84M	0.93M	0.68M	0.23M	0.68M	0.30M	0.38M
Inventory			0.99M	1.42M	2.49M	1.78M	1.61M	1.33M	1.62M	1.13M	0.74M	1.19M	1.24M	1.22M	1.10M	0.81M	0.96M	0.89M	0.95M
Prepaid Assets	0.96M	0.32M	0.14M	1.31M	0.80M	0.36M	0.83M	0.70M	0.50M	0.22M	1.11M	1.02M	0.48M	0.15M	0.64M	0.51M	0.32M	0.19M	0.66M	0.62M
Current Assets	8.38M	15.98M	12.51M	8.75M	9.60M	11.54M	14.02M	11.84M	11.33M	8.30M	11.81M	10.06M	8.69M	7.28M	5.47M	6.41M	12.87M	10.80M	8.79M	6.89M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)	0.33M	0.30M	1.10M	1.00M	0.90M	0.80M	0.70M	0.75M	0.72M	0.62M	1.48M	1.37M	1.25M	1.34M	1.23M	1.11M	0.99M	0.88M	0.76M	0.64M
Goodwill	1.74M		2.02M	2.02M	1.14M				1.08M
Intangibles	1.74M	1.74M	2.40M	2.36M	2.11M	2.07M	2.03M	1.99M	0.30M	2.93M	2.93M	2.93M	2.93M	2.93M	2.93M	2.93M	2.93M	2.93M	2.93M	2.93M
Goodwill & Intangibles	3.47M	1.74M	4.42M	4.38M	3.25M	2.07M	2.03M	1.99M	1.38M	2.93M	2.93M	2.93M	2.93M	2.93M	2.93M	2.93M	2.93M	2.93M	2.93M	2.93M
Long-Term Deferred Tax	13.97M				18.75M				21.24M				7.50M				5.40M
Other Non-Current Assets	0.01M	0.01M	0.11M	0.11M	0.18M	0.17M	0.17M	0.15M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	1.76M	0.10M	0.10M	1.07M
Non-Current Assets	1.40M	1.35M	6.88M	6.74M	3.19M	3.04M	2.90M	2.89M	2.77M	2.62M	3.45M	3.29M	3.13M	3.19M	3.03M	2.87M	2.71M	2.56M	2.40M	2.25M
Assets	9.78M	17.33M	19.38M	15.49M	12.79M	14.58M	16.92M	14.73M	14.11M	10.92M	15.26M	13.36M	11.82M	10.47M	8.50M	9.28M	15.58M	13.36M	11.19M	9.13M
Liabilities
Current Liabilities
Accounts Payables	2.13M	1.92M	3.36M	2.87M	2.42M	2.36M	1.97M	1.83M	1.61M	1.05M	1.29M	1.18M	1.65M	1.01M	1.37M	1.41M	1.23M	1.13M	1.07M	1.01M
Notes Payables			0.06M	0.03M
Payables	2.13M	1.92M	3.42M	2.90M	2.42M	2.36M	1.97M	1.83M	1.61M	1.05M	1.29M	1.18M	1.65M	1.01M	1.37M	1.41M	1.23M	1.13M	1.07M	1.01M
Accumulated Expenses	0.17M	0.14M	0.38M	0.12M	0.14M				0.54M	0.28M	0.10M	0.21M	0.49M	0.24M	0.34M	0.46M	0.42M	0.27M	0.38M	0.37M
Other Accumulated Expenses	2.22M				3.18M	3.28M	2.40M	2.27M
Short term Debt			0.06M	0.03M
Current Leases	0.08M	0.08M	0.39M	0.40M	0.40M	0.40M	0.41M	0.42M	0.38M	0.29M	0.36M	0.35M	0.32M	0.42M	0.42M	0.43M	0.44M	0.42M	0.41M	0.39M
Current Deferred Revenue			0.01M	0.01M		0.02M	0.02M	0.02M	0.02M		0.03M
Total Current Liabilities	2.22M	1.93M	4.62M	4.11M	3.32M	3.28M	2.40M	2.27M	2.00M	1.34M	1.68M	1.53M	1.97M	1.44M	1.79M	1.84M	1.84M	1.55M	1.48M	2.21M
Non-Current Liabilities
Liabilities from Discontinued OperationsLiabilities from Discont. Ops																	0.17M			0.81M
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax					0.07M				0.21M								0.02M
Operating Leases	0.19M	0.18M	0.83M	0.83M	0.39M	0.29M	0.18M	0.07M	0.02M	0.29M	1.17M	0.73M	0.64M	1.06M	0.53M	0.42M	0.31M	0.22M	0.12M	0.03M
Other Non-Current Liabilities
Total Non-Current Liabilities
Total Liabilities	2.40M	2.11M	5.22M	4.60M	3.71M	3.58M	2.58M	2.34M	2.02M	1.34M	2.48M	2.25M	2.62M	2.07M	2.32M	2.26M	2.15M	1.77M	1.60M	2.24M
Shareholder's Equity
Total Debt			0.12M	0.06M
Common Equity	7.38M	15.22M	14.17M	10.89M	9.08M	11.01M	14.34M	12.39M	12.09M	-9.58M	12.77M	11.10M	9.21M	8.40M	6.18M	7.02M	13.43M	11.59M	9.59M	6.89M
Liabilities and Shareholders Equity	9.78M	17.33M	19.38M	15.49M	12.79M	14.58M	16.92M	14.73M	14.11M	10.92M	15.26M	13.36M	11.82M	10.47M	8.50M	9.28M	15.58M	13.36M	11.19M	9.13M
Retained Earnings	-74.85M	-77.82M	-82.11M	85.60M	-93.45M	97.00M	99.10M	101.10M	-101.40M	-103.94M	-105.42M	-107.14M	-109.08M	-110.80M	-113.33M	-115.45M	-117.24M	-119.00M	-121.00M	-124.00M

InMed Pharmaceuticals INM Balance Sheet (2019-2026)

InMed Pharmaceuticals Quarterly Balance Sheet

Create an account

Sign In

Reset Password